companydata.dkEPITHERAPEUTICS ApS: Financial statements 2013
CVR: 30523067
EPITHERAPEUTICS ApS (CVR 30523067) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -20,667,009 and a net result of DKK -34,462,624 compared with DKK -26,646,160 the year before. Equity amounted to DKK 15,701,326. The solvency ratio was 54.6%.
- Gross Profit
- -20,667,009 kr.
- Profit/Loss
- -34,462,624 kr.
- Equity
- 15,701,326 kr.
- Total Assets
- 28,757,929 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -20.7 mio. | -34.5 mio. | 15.7 mio. | - |
| 2012 | - | -11.9 mio. | -26.6 mio. | -9.1 mio. | - |
Find more companies like EPITHERAPEUTICS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
As of October 24, 2013, Georges Gemayel is registered as chairman of EPITHERAPEUTICS ApS.
As of October 24, 2013, Peter Høngård Andersen has stepped down as chairman of EPITHERAPEUTICS ApS.
EPITHERAPEUTICS ApS has published its annual report for 2012. Gross profit came to DKK -11,928,543, and the net result was DKK -26,646,160.
As of January 8, 2013, JUT NR. 2180 A/S has been appointed auditor of EPITHERAPEUTICS ApS.
As of January 8, 2013, EY Danmark A/S has stepped down as auditor of EPITHERAPEUTICS ApS.
About EPITHERAPEUTICS ApS
EPITHERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2008 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee. In 2021, the company reported a gross profit of DKK 72,058 and a net result of DKK -21,073,661 compared with DKK -3,028,693 the year before. Equity amounted to DKK 9,205,571.